Indocyanine green mediated photothrombosis for the management of predominantly classic choroidal neovascularisation caused by age related macular degeneration

British Journal of Ophthalmology

Volumn 88, Issue 8, 2004, Pages 1055-1059

  Farah, M E ^a,b   Cardillo, J A ^b   Luzardo, A C ^b   Calucci, D ^b   Williams, G A ^c   Costa, R A ^b  

^a Paulista School of Medicine ^*  (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; INDOCYANINE GREEN;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DEATH; FEMALE; FOLLOW UP; HUMAN; LASER; LASER COAGULATION; LIGHT IRRADIANCE; MALE; OUTCOMES RESEARCH; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT FAILURE; TREATMENT OUTCOME; VISION; VISUAL ACUITY; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; LIGHT COAGULATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 3542993911     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.035808     Document Type: Article

References (14)

1. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results 2 randomized trials-Report 1. Arch Ophthalmol 1999;117;1329-45.
2. VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-60.
3. Costa RA, Farah ME, Cardillo JA, et al. Immediate indocyonine green angiography and optical coherence tomography evaluation after photodynamic therapy of subfoveal choroidal neovascularization. Retina 2003;23:159-65.
4. Costa RA, Farah ME, Freymüller E, et al. Choriocapillaris photodynamic therapy using indocyanine green. Am J Ophthalmol 2001;132:557-65.
5. Paumgartner G, Probst P, Kraines R, et al. Kinetics of indocyanine green removal from the blood. NY Acad Sci 1970;170:134-70.
6. Fox I, Brooker G, Heseltine D, et al. New dyes for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Am J Physiol 1956;187:599-606.
7. Costa RA, Farah ME, Cardillo JA, et al. Photodynamic therapy using ICG for the treatment of occult choroidal neovascularization. Curr Eye Res 2001;23:271-5.
8. Costa RA, Scapucin L, Moraes NS, et al. Indocyanine green-mediated photothrombosis as a new technique of treatment for persistent central serous chorioretinopathy. Curr Eye Res 2002;25:287-97.
9. Navajas EV, Costa RA, Farah ME, et al. Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularization in serpiginous choroiditis. Eye 2003;17:563-6.
10. Roizenblatt R, Farah ME, Castro J, et al. Diode laser modifications for treatment of choroidal neovascularization. Lasers Med Sci 2003;18:43-4.
11. Grossweiner LI. The science of phototherapy. Boca Raton, FL: CRC Press, 1994, 27-49,139-155,175-7.
12. Baumler W, Abels C, Karrer S, et al. Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 1999;80:360-3.
13. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis, and heat shock proteins. Ophthalmic Surg Lasers 2000;31:359-73.
14. Sharma S, Brown GC, Brown MM, et al. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2001;108:2051-9.